Search results :

Forteo

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: H05AA02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Pain common, 21.3% 20.5% x x x x x x x
Arthralgia uncommon, 10.1% 8.4% x x x x x x x
Rhinitis 9.6% 8.8% x x x x x x
Asthenia 8.7% 6.8% x x x x x x
Nausea 8.5% 6.7% x x x x x x x
Dizziness 8% 5.4% x x x x x x x
Headache 7.5% 7.4% x x x x x x x
Hypertension 7.1% 6.8% x x x x x x
Cough increased 6.4% 5.5% x x x x x x
Pharyngitis 5.5% 4.8% x x x x x x
Constipation 5.4% 4.5% x x x x x x
Dyspepsia 5.2% 4.1% x x x x x x
Diarrhoea 5.1% 4.6% x x x x x x
Contusion postmarketing, common x x x x x x
Fatigue common x
Haemorrhage common x x
Pruritus common x x x x x
Swelling postmarketing, common x x x x x x
Erythema common x x x x x
Rash 4.9% 4.5% x x x x x x
Insomnia 4.3% 3.6% x x x x x x
Depression 4.1% 2.7% x x x x x x x
Pneumonia 3.9% 3.3% x x x x x x
Vertigo 3.8% 2.7% x x x x x x x
Dyspnoea 3.6% 2.6% x x x x x x x
Neck pain 3% 2.7% x x x x x x
Vomiting 3% 2.3% x x x x x x x
Cramps of lower extremities 2.6% 1.3% x x x x x x
Syncope 2.6% 1.4% x x x x x x x
Angina pectoris 2.5% 1.6% x x x x x x
Gastrointestinal disorder 2.3% 2% x x x x x x x
Sweating 2.2% 1.7% x x x x x x
Tooth disorder 2% 1.3% x x x x x x
Myalgia uncommon x x
Anaphylactic shock postmarketing x
Angioedema postmarketing x
Bone neoplasm postmarketing x
Chest pain postmarketing — common x x x x x x
Drug hypersensitivity postmarketing x
Oedema rare x x
Hypercalcaemia postmarketing — uncommon x x x x x x x
Hypersensitivity postmarketing x
Osteosarcoma postmarketing x
Muscle spasms very rare — common x x x x
Urticaria postmarketing x x
Injection site reaction postmarketing x x
Injection site pain postmarketing x
Face oedema postmarketing x x x
Hyperuricaemia postmarketing 0.7% x x x
Acute dyspnea postmarketing, rare x x x x x x
Generalized urticaria postmarketing, rare x x x x
Orofacial oedema postmarketing x
Anaemia x
Anxiety x
Mental disorder x
Bone disorder x
Connective tissue disorder x
Gastritis x
Gastrooesophageal reflux disease x
Gout x x
Cardiac disorder x
Cardiac murmur x
Haemorrhoids x
Herpes zoster x
Hypercalciuria x
Hypercholesterolaemia x
Hypotension x
Low back pain x
Mediastinal disorder x
Cramp muscle x
Nervous system disorder x
Pain in extremity x
Palpitations x
Polyuria x
Emphysema x
Renal failure x
Sciatica x
Tachycardia x
Urinary incontinence x
Urinary tract disorder x
Angiopathy x
Weight increased x
Micturition urgency x
Injection site haemorrhage x x x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x
Fatal outcomes x
Osteosarcoma metastatic x
Nephrolithiasis x
Urolithiasis x x
Sweating increased x
Blood and lymphatic system disorders x
Ear and labyrinth disorders x
Injection site erythema x
Hiatus hernia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

rDNA origin / Forteo [teriparatide

Side effects:28
Source:FDA

TERIPARATIDE RECOMBINANT HUMAN / FORTEO

Side effects:37
Source:FDA

rDNA origin / Forteo teriparatide

Side effects:38
Source:FDA

TERIPARATIDE RECOMBINANT HUMAN / FORTEO

Side effects:38
Source:FDA

Teriparatide (rbe) Injection / FORTEO

Side effects:45
Source:medicines.org.au

Teriparatide

Side effects:50
Source:FDA Structured Product Label

teriparatide / teriparatide

Side effects:59
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label